algos database
Russian translation: алгоритмы
| GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
|---|---|---|---|---|---|---|
|
| 16:31 Apr 30, 2004 |
| English to Russian translations [PRO] Science - Chemistry; Chem Sci/Eng / MSDS | |||||||
|---|---|---|---|---|---|---|---|
|
| ||||||
|  Selected response from: Marina Aleyeva Israel Local time: 17:29 | ||||||
Grading comment
| |||||||
| Summary of answers provided | ||||
|---|---|---|---|---|
| 4 +1 | база данных углеводородных соединений |
| ||
| 2 +1 | см. ниже |
| ||
| 1 | алгоритмы |
|
| Discussion entries: 1 | |
|---|---|
Answers
20 mins confidence: 
peer agreement (net): +1
peer agreement (net): +1база данных углеводородных соединений Explanation: Алканы (Alkanes) = насыщенные углеводородные соединения Алкены (Alkenes) = ненасыщенные углеводородные соединения |
| |
| Login to enter a peer comment (or grade) | ||
2 hrs confidence: peer agreement (net): +1
peer agreement (net): +1см. ниже Explanation: греч. ¶algos боль Только предположения: база данных Algos база данных [компании] Алгос база данных анальгетиков http://www.algosinc.com/VisionFrameset.htm ***Algos Therapeutics, Inc.*** is a pain-focused drug discovery company developing breakthrough treatments for painful chronic conditions. Algos’ specialized behavioral models mimic chronic pain states in humans and serve as powerful tools for evaluating drug candidates. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&DB... Curr Opin Investig Drugs. 2002 Mar;3(3):459-62 Endo Pharmaceuticals. Monck N. Endo (which acquired ***Algos*** in July 2000) has developed EN-3231, a combination of morphine and dextromethorphan, for the treatment of moderate-to-severe chronic pain. In October 1998, the FDA accepted for filing the company's NDA submission on EN-3231, which was submitted in August 1998. However, in August 1999, Algos received a 'non-approvable' letter from the FDA for EN-3231. In September 2000, the company met with the FDA to discuss what information the FDA required in order to approve EN-3231. The FDA requested a second pivotal trial, which Endo initiated promptly. Endo hoped to file its supplement to the NDA during 2002. |
| |||||||||||||
4 hrs confidence:
Login or register (free and only takes a few minutes) to participate in this question. You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy. KudoZ™ translation helpThe KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases.
See also: Search millions of term translations Your current localization setting
English
Select a language Close search
| ||||||||||||||
